Associated Papers
Development of a live cell assay for the zinc transporter ZnT8.
Azzollini L et al.
Slas Discovery : Advancing Life Sciences R & D, 2024
Diabetes and Genetics: A Relationship Between Genetic Risk Alleles, Clinical Phenotypes and Therapeutic Approaches.
Sayed S et al.
Advances in Experimental Medicine and Biology, 2021
Next Generation Exome Sequencing of Pediatric Asthma Identifies Rare and Novel Variants in Candidate Genes.
Bogari NM et al.
Disease Markers, 2021
The genetic landscape of the human solute carrier (SLC) transporter superfamily.
Schaller L et al.
Human Genetics, 2019
Genetic, Functional, and Immunological Study of ZnT8 in Diabetes.
Huang Q et al.
International Journal of Endocrinology, 2019
A low-frequency GLIS3 variant associated with resistance to Japanese type 1 diabetes.
Awata T et al.
Biochemical and Biophysical Research Communications, 2013
Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
Mannino GC et al.
Molecular Diagnosis & Therapy, 2012
Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
Huang Q et al.
European Journal of Clinical Pharmacology, 2010
Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese.
Xiang J et al.
The Journal of Clinical Endocrinology and Metabolism, 2008
Mutations in the SLC30A8 gene are not a major cause of MODY or other forms of early-onset, autosomal dominant type 2 diabetes.
Borowiec M et al.
Diabetologia, 2007
Select a paper to view details